Fundz

Autobahn Therapeutics reported raising $101 Million in an initial SEC Form D filing, from an offering of $120 Million

PRIVATEAug 01, 2024$100.8M of $120M raised

Amount Raised

$101 Million

$101 Million sold, per SEC Form D (first sale Jun 20, 2024)

Round Type

Venture

San DiegoBiotechnologyHealth CareTherapeutics

Quick answer

Autobahn Therapeutics raised $101 Million in a funding round, dated June 20, 2024. Autobahn Therapeutics is based in San Diego, California, United States.

How much did Autobahn Therapeutics raise?
Autobahn Therapeutics raised $101 Million in a funding round on June 20, 2024.
What does Autobahn Therapeutics do?
Autobahn Therapeutics is focused on restoring hope for people affected by CNS disorders.
Where is Autobahn Therapeutics based and how big is it?
Autobahn Therapeutics is based in San Diego, California, United States.
Who are the decision-makers at Autobahn Therapeutics?
Fundz holds 1 contact at Autobahn Therapeutics, including the Senior Director - Translational Neuroscience. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who to call at Autobahn Therapeutics, and when

A new round usually means Autobahn Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Autobahn Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Autobahn Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Autobahn Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Autobahn Therapeutics

Location

San Diego, California, United States

About

Autobahn Therapeutics is focused on restoring hope for people affected by CNS disorders. Leveraging its proprietary brain-targeting chemistry platform, Autobahn aims to unlock new therapeutic opportunities through precision tuning of the central exposure of its molecules. The company’s pipeline is led by ABX-002, a thyroid hormone receptor beta agonist, being developed initially for people with treatment-resistant depression. Autobahn Therapeutics is based in San Diego.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Autobahn Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsJeffrey V., Senior Director - Translational Neuros… hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Autobahn Therapeutics's next move

See what Strategic adds

Autobahn Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.